We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Thyroid Cancer Risk and C-Cell Findings. Concerns about medullary thyroid carcinoma emerged from rodent studies showing increased calcitonin secretion ..."
"In Japan, SEL was approved in 2022 for the treatment of RET fusion-positive thyroid cancer and medullary thyroid carcinoma harboring RET mutations."
"... Retevmo in early stage lung cancer. For you as an investor, these ... Lilly also reported a positive Phase 3 trial result for its cancer drug Retevmo in ..."
"Medullary thyroid carcinoma (MTC) is a heterogeneous neuroendocrine malignancy in which outcomes are shaped by tumor burden, locoregional spread, ..."
"... zanzalintinib. The firm's confidence in zanzalintinib is bolstered by promising data, particularly in metastatic colorectal cancer (mCRC), as ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.